paclitaxel has been researched along with Cancer of Nose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastien, C; Campitiello, M; Gehin, W; Hennequin, L; Jaud, C; Longo, R; Plastino, F; Rozzi, A | 1 |
| Barker, CA; Cohen, MA; Cracchiolo, JR; Dunn, LA; Ganly, I; Katabi, N; Lee, A; Lee, N; Mah, D; McBride, S; McGill, M; Mimica, X; Sine, K; Yu, Y | 1 |
2 other study(ies) available for paclitaxel and Cancer of Nose
| Article | Year |
|---|---|
Renal Metastases from a Nasal Cavity Mixed Squamous Cell and Adenoid Cystic Carcinoma: A Case Report.
Topics: Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cetuximab; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nasal Cavity; Nose Neoplasms; Paclitaxel; Palliative Care; Positron-Emission Tomography; Rare Diseases | 2020 |
Organ preservation for patients with anterior mucosal squamous cell carcinoma of the nasal cavity: Rhinectomy-free survival in those refusing surgery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nasal Cavity; Nose; Nose Neoplasms; Organ Sparing Treatments; Paclitaxel; Radiotherapy, Intensity-Modulated; Retrospective Studies | 2019 |